Collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma.

Researchers

Journal

Modalities

Models

Abstract

The reporting of tumour cellularity in cancer samples has become a mandatory task for pathologists. However, the estimation of tumour cellularity is often inaccurate. Therefore, we propose a collaborative workflow between pathologists and artificial intelligence (AI) models to evaluate tumour cellularity in lung cancer samples and propose a protocol to apply it to routine practice.We developed a quantitative model of lung adenocarcinoma that we validated and tested on 50 cases, and a collaborative workflow where pathologists could access the AI results and adjust their original tumour cellularity scores (Adjusted-Score) that we tested on 151 cases. The Adjusted-Score was validated by comparing them with a ground truth established by manual annotation of haematoxylin-eosin slides with reference to immunostains with thyroid transcription factor-1 and napsin A. For training, validation, testing the AI, and testing the collaborative workflow, we used 40, 10, 50, and 151 whole slide images of lung adenocarcinoma respectively. The sensitivity and specificity of tumour segmentation were 97% and 87% respectively, and the accuracy of nuclei recognition was 99%. One pathologist’s visually estimated scores were compared to the Adjusted-Score, and the pathologist’s scores were altered in 87% of cases. Comparison with the ground truth revealed that the Adjusted-Score was more precise than the Path-Score (p<0.05).We proposed a collaborative workflow between AI and pathologists as a model to improve daily practice and enhance the prediction of tumour cellularity for genetic tests.This article is protected by copyright. All rights reserved.